HomeCompareSCTY vs MRK

SCTY vs MRK: Dividend Comparison 2026

SCTY yields 40000.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SCTY wins by $5.18024517379999e+22M in total portfolio value
10 years
SCTY
SCTY
● Live price
40000.00%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.18024517379999e+22M
Annual income
$51,548,940,318,215,365,000,000,000,000.00
Full SCTY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SCTY vs MRK

📍 SCTY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSCTYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SCTY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SCTY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SCTY
Annual income on $10K today (after 15% tax)
$3,400,000.00/yr
After 10yr DRIP, annual income (after tax)
$43,816,599,270,483,060,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SCTY beats the other by $43,816,599,270,483,060,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SCTY + MRK for your $10,000?

SCTY: 50%MRK: 50%
100% MRK50/50100% SCTY
Portfolio after 10yr
$2.590122586899995e+22M
Annual income
$25,774,470,159,107,683,000,000,000,000.00/yr
Blended yield
99.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SCTY
Analyst Ratings
2
Hold
1
Sell
Consensus: Hold
Altman Z
0.1
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SCTY buys
0
MRK buys
0
No recent congressional trades found for SCTY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSCTYMRK
Forward yield40000.00%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$5.18024517379999e+22M$56.8K
Annual income after 10y$51,548,940,318,215,365,000,000,000,000.00$9,798.13
Total dividends collected$5.178579568047658e+22M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: SCTY vs MRK ($10,000, DRIP)

YearSCTY PortfolioSCTY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$4,010,700$4,000,000.00$11,206$366.19+$4.00MSCTY
2$1,503,618,552$1,499,327,102.80$12,650$502.35+$1503.61MSCTY
3$526,936,342,129$525,327,470,278.19$14,407$694.19+$526936.33MSCTY
4$172,618,628,820,566$172,054,806,934,488.28$16,585$967.82+$172618628.80MSCTY
5$52,860,672,107,805,460$52,675,970,174,967,450.00$19,342$1,363.89+$52860672107.79MSCTY
6$15,132,132,379,588,594,000$15,075,571,460,433,242,000.00$22,913$1,947.19+$15132132379588.57MSCTY
7$4,049,462,878,006,525,600,000$4,033,271,496,360,366,000,000.00$27,662$2,823.89+$4049462878006525.50MSCTY
8$1,013,053,710,099,385,500,000,000$1,008,720,784,819,918,400,000,000.00$34,159$4,173.35+$1013053710099385472.00MSCTY
9$236,926,560,546,299,530,000,000,000$235,842,593,076,493,200,000,000,000.00$43,337$6,308.80+$236926560546299510784.00MSCTY
10$51,802,451,737,999,890,000,000,000,000$51,548,940,318,215,365,000,000,000,000.00$56,776$9,798.13+$5.18024517379999e+22MSCTY

SCTY vs MRK: Complete Analysis 2026

SCTYStock

Monitronics International, Inc., doing business as Brinks Home Security, provides security alarm monitoring and related services to residential and commercial customers in the United States, Canada, and Puerto Rico. It provides monitoring services for alarm signals arising from burglaries, fires, medical alerts, and other events through security systems at customers' premises. The company also offers home automation and life safety services, such as remote activation and control of security systems; support for video monitoring, flood sensors, and automated garage door and door lock capabilities; and thermostat integration services. In addition, it provides hands-free two-way interactive voice communication between its monitoring center and customers; customer and technical support related services to home monitoring systems and home automation services; and do-it-yourself and professional installation security solutions. It serves its customers through a network of authorized dealers. The company was founded in 1994 and is based in Farmers Branch, Texas.

Full SCTY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SCTY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SCTY vs SCHDSCTY vs JEPISCTY vs OSCTY vs KOSCTY vs MAINSCTY vs JNJSCTY vs ABBVSCTY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.